TY  - GEN
AU  - Bowles,D W
AU  - Ma,W W
AU  - Senzer,N
AU  - Brahmer,J R
AU  - Adjei,A A
AU  - Davies,M
AU  - Lazar,A J
AU  - Vo,A
AU  - Peterson,S
AU  - Walker,L
AU  - Hausman,D
AU  - Rudin,C M
AU  - Jimeno,A
TI  - A multicenter phase 1 study of PX-866 in combination with docetaxel in patients with advanced solid tumours
SN  - 1532-1827
PY  - 2013///1115
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Biomarkers, Tumor
KW  - blood
KW  - Disease-Free Survival
KW  - Docetaxel
KW  - Female
KW  - Gonanes
KW  - Humans
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Neoplasms
KW  - drug therapy
KW  - Phosphoinositide-3 Kinase Inhibitors
KW  - Taxoids
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/bjc.2013.474
ER  -